One specific type of viral exanthem that dermatologists have seen with COVID is a morbilliform rash, meaning a measles-like rash. Measles rashes tend to look like small raised bumps that eventually ...

In the UK, people living with certain types of dementia, can be prescribed treatments to help manage their symptoms. These are known as symptomatic treatments. They include donepezil (part of a family ...

In newborns, a culture of the belly button may also be done. Treatment will depend on your child’s symptoms, age, and general health. It will also depend on how severe the condition is. Your child ...

in combination with Keytruda, Merck’s anti-PD-1 therapy, as adjuvant treatment for patients with resectable Stage II, IIIA or IIIB non-small cell lung cancer who did not achieve a pathological ...

The INTerpath-009 trial will investigate an individualized neoantigen therapy plus Keytruda in patients with non-small cell lung cancer post-surgery whose disease didn't fully respond to prior ...

NEW YORK – Moderna and Merck will test their personalized neoantigen cancer vaccine V940 with Merck's checkpoint inhibitor Keytruda (pembrolizumab ... The firms are also evaluating V940 as an adjuvant ...

The first approval is for use with carboplatin and paclitaxel as a first-line treatment for adults with primary advanced or recurrent endometrial carcinoma who are eligible for systemic therapy. The ...

Professor Hawthorne empathised with those affected, remarking: "We recognise that patients may be apprehensive to seek treatment given the social stigma that surrounds the condition, but it is imp ...

"These approvals underscore the continued expansion of the use of KEYTRUDA in diverse patient populations and treatment settings with utility of KEYTRUDA ranging from earlier lines of therapy to ...

“These approvals underscore the continued expansion of the use of KEYTRUDA in diverse patient populations and treatment settings with utility of KEYTRUDA ranging from earlier lines of therapy to ...

has occurred with anti– PD-1/PD-L1 treatments. Topical emollients and/or topical corticosteroids may be adequate to treat mild to moderate nonexfoliative rashes. Withhold or permanently discontinue ...